Technology
IQSTEL
Upcoming July 22, 2026
IQSTEL (NASDAQ: IQST) has built a technology platform that is at the intersection of telecom, AI, fintech, and cybersecurity
IQSTEL (NASDAQ: IQST) has built a technology platform that is at the intersection of telecom, AI, fintech, and cybersecurity
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
IQSTEL (NASDAQ: IQST) reaches over 600 telecom operators with access to approximately 2.3 billion end users around the world.
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform